| Initial public issue of upto 22,90,800 equity shares of face value of Rs. 10 each ("equity shares") of Medibios Laboratoies Limited ("The Company" or "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Issue price") aggregating to Rs. [*] crores ("Issue") consisting of a fresh issue of upto 15,55,200 equity shares of face value of Rs. 10 each ("equity shares") for cash at a price of Rs. [*] per equity share aggregating to Rs. [*] crores ("Issue") and [*] equity shares of face value of Rs. 10 each ("equity shares") for cash at a price of Rs. [*] per equity share aggregating to Rs. [*] crores through an offer for sale by Emil Pharmaceutical Industries Private Limited of which upto 1,15,200 equity shares of face value of Rs. 10 each for a cash price of Rs. [*] per equity share, aggregating to Rs. [*] crores will be reserved for subscription by market maker ("market maker reservation portion"). The issue less the market maker reservation portion i.e. Issue of upto 21,75,600 equity shares of face value of Rs. [*] each at an issue price of Rs. [*] per equity share aggregating to Rs. [*] crores (The "Net Issue"). The issue and the net issue will constitute [*]% and [*]%, respectively of the post issue paid up equity share capital of the company.
The Face value of the equity shares is Rs. 10.00 each and the issue price is [*]. The issue price is [*] times of the face value.
|
